# Manuscript Validation Report

**Generated:** 2026-02-25 11:07
**Manuscript:** Revised Manuscript_2-1-26.docx
**Codebase:** ERpBRCA_OlderWomen (refactored)

## Executive Summary

| Tier | Total | PASS/EXACT | REVIEW/CLOSE | FAIL/DIFFERS | PENDING |
|------|-------|------------|--------------|--------------|---------|
| Numerical | 65 | 13 | 2 | 0 | 12 |
| Visual | 2 | 1 | 1 | 0 | 0 |
| Claims | 65 | 0 | 13 | 0 | 13 |

**Overall Status:** REVIEW - Manual Verification Needed

---

## Tier 1: Numerical Validation

Programmatic comparison of quantitative claims to code outputs.

- ? **percentage**: 60% → None
- ? **percentage**: 70% → None
- ? **percentage**: 80% → None
- ? **percentage**: 90% → None
- ? **p_value**: p < 0.0001 → None
- ? **p_value**: p < 0.0001 → None
- ? **p_value**: p = 0.0015 → None
- ? **p_value**: p = 0.06 → None
- ? **p_value**: p = 0.02 → None
- ? **p_value**: p = 0.02 → None
- ? **p_value**: p = 0.04 → None
- ? **sample_size**: n = 20 → None
- ? **sample_size**: n = 17 → None
- ? **p_value**: p = 0.10 → None
- ? **p_value**: p < 0.05 → None
- ? **sample_size**: n = 115 → None
- ? **sample_size**: n = 89 → None
- ✓ **p_value**: p = 0.0033 → 0.0033007519217515
- ✓ **p_value**: p = 0.99 → 1.0
- ~ **p_value**: p = 0.012 → 0.0092282017973772

*... and 45 more claims*

---

## Tier 2: Visual Validation

Azure OpenAI GPT-5 vision comparison of figure pairs.

- ✓ **Fig. 2_A_oncoplot**: PASS
  - Sample order slightly differs between figures (e.g., 157_O and 158_O positions).
  - Color palette tones vary slightly but maintain same categorical mapping.
  - Font size and layout spacing differ between original and regenerated versions.
- ~ **Fig. 2_B_cosmic**: REVIEW
  - Sample order differs between figures (Y/O labels swapped or reordered)
  - Title present only in regenerated figure ('SBS Signature Counts per Sample')
  - Legend order and colors consistent but placement slightly different

---

## Tier 3: Claim Verification

Text-to-data verification of manuscript claims.

- ? The biology of breast cancer is age-dependent 1,2. Estrogen receptor positive (E...
- ? The biology of breast cancer is age-dependent 1,2. Estrogen receptor positive (E...
- ? The biology of breast cancer is age-dependent 1,2. Estrogen receptor positive (E...
- ? The biology of breast cancer is age-dependent 1,2. Estrogen receptor positive (E...
- ? Younger rats (n = 20) were treated with the carcinogen at 4 months of age while ...
- ? Younger rats (n = 20) were treated with the carcinogen at 4 months of age while ...
- ? Younger rats (n = 20) were treated with the carcinogen at 4 months of age while ...
- ? Younger rats (n = 20) were treated with the carcinogen at 4 months of age while ...
- ? Younger rats (n = 20) were treated with the carcinogen at 4 months of age while ...
- ? Younger rats (n = 20) were treated with the carcinogen at 4 months of age while ...
- ? Younger rats (n = 20) were treated with the carcinogen at 4 months of age while ...
- ? Younger rats (n = 20) were treated with the carcinogen at 4 months of age while ...
- ? Younger rats (n = 20) were treated with the carcinogen at 4 months of age while ...
- ? With these quantitative and phenotypic differences tumors that developed in youn...
- ? With these quantitative and phenotypic differences tumors that developed in youn...
- ? We next constructed two cohorts of human specimens to investigate changes in bot...
- ? We next constructed two cohorts of human specimens to investigate changes in bot...
- ? We next investigated estrogen disposition in the normal breast microenvironment ...
- ? We next investigated estrogen disposition in the normal breast microenvironment ...
- ? To decipher how E2 is synthesized in the breast, we examined a panel of genes en...

*... and 45 more claims*

---

## Figures Requiring Review


### Needs Manual Review

- **Fig. 2_B_cosmic**: Both figures show consistent SBS signature distributions and relative contributions across samples, supporting the same scientific conclusion. However, sample order and minor formatting differences suggest the regenerated figure should be reviewed for label alignment and presentation consistency.

---

## Appendix: Scope

### Computational Figures (In Scope)

- Fig. 2
- Fig. 4
- Fig. 6
- Fig. 7
- EDF 2
- EDF 5
- EDF 6
- EDF 7
- EDF 10

### Wet Lab Figures (Out of Scope)

- Fig. 1
- Fig. 3
- Fig. 5
- Fig. 8
- EDF 1
- EDF 3
- EDF 4
- EDF 8
